Mechanisms of allergen specific immunotherapy – T‐cell tolerance and more

Abstract

Specific immune suppression and induction of tolerance are essential processes in the regulation and circumvention of immune defence. The balance between allergen‐specific T‐regulatory (Treg) cells and T helper 2 cells appears to be decisive in the development of allergic and healthy immune response against allergens. Treg cells consistently represent the dominant subset specific for common environmental allergens in healthy individuals. In contrast, there is a high frequency of allergen‐specific T helper 2 cells in allergic individuals. A decrease in interleukin (IL)‐4, IL‐5 and IL‐13 production by allergen‐specific CD4⁺ T cells due to the induction of peripheral T cell tolerance is the most essential step in allergen‐specific immunotherapy (SIT). Suppressed proliferative and cytokine responses against the major allergens are induced by multiple suppressor factors, such as cytokines like IL‐10 and transforming growth factor (TGF)‐β and cell surface molecules like cytotoxic T lymphocyte antigen‐4, programmed death‐1 and histamine receptor 2. There is considerable rationale for targeting T cells to increase efficacy of SIT. Such novel approaches include the use of modified allergens produced using recombinant DNA technology and adjuvants or additional drugs, which may increase the generation of allergen‐specific peripheral tolerance. By the application of the recent knowledge in Treg cells and related mechanisms of peripheral tolerance, more rational and safer approaches are awaiting for the future of prevention and cure of allergic diseases.